Purpose: Advances in surgical techniques, evolving patient demographics, and the expansion of perioperative care have fundamentally reshaped the objectives of modern anesthesia. Beyond maintaining intraoperative unconsciousness and physiological stability, anesthesia is now increasingly expected to influence postoperative recovery and long-term outcomes. This review examines how recent drug-centered innovations are transforming approaches to anesthesia, analgesia, and postoperative recovery and discusses their implications for the future direction of anesthetic practice.Current concepts: Modern anesthesia is delivered within a highly standardized, technology-driven environment that provides a high level of intraoperative safety. Nevertheless, substantial variability persists in postoperative recovery, neurocognitive outcomes, and complication rates, even among patients undergoing similar surgical procedures. Increasing evidence suggests that these differences are closely associated with the pharmacokinetic and pharmacodynamic properties of anesthetic agents. Accordingly, recent advances have emphasized reversibility, predictability, minimization of residual effects, and recovery-oriented pharmacology. Anesthetic agents with predictable recovery profiles, opioid-sparing multimodal analgesic strategies, and rapid neuromuscular blockade reversal exemplify this transition toward recovery-focused anesthesia management.Discussion and conclusion: Anesthetic strategies are evolving from depth-centered control toward the intentional design of recovery trajectories. Pain management is being restructured to reduce opioid-related adverse effects while promoting functional recovery through multimodal, non-opioid-based approaches. Concurrently, the emergence of reversibility as a core safety principle has reshaped anesthetic decision-making. The selection of anesthetic agents represents a central determinant of postoperative recovery, complications, and patient-centered outcomes. Anesthesia should no longer be viewed solely as a transient intraoperative intervention but rather as a deliberately designed, prognostically influential intervention grounded in strategic, evidence-based pharmacologic decision-making.
Kim et al. (Fri,) studied this question.